According to Schroders, there are several reasons to be optimistic about Mexico’s macroeconomic landscape, explaining why emerging market (EM) fund managers are bullish on Mexico. The country benefits from a strong export relationship with the United States, which remains robust, and the prospect of nearshoring as a significant driver of future economic growth. Additionally, Mexico’s demographic profile, with over half of its population under 30 years old, supports long-term economic potential. These factors align with what Schroders identifies as the “3D Reset” trends: deglobalisation, demographics, and decarbonisation.
The future, however, holds uncertainties. Policy concerns have persisted under President Andrés Manuel López Obrador’s administration. Upcoming presidential, congressional, and gubernatorial elections in June add to the potential for volatility. Furthermore, the future of the US-Mexico-Canada (USMCA) trade agreement, due for review in 2026, will be crucial for Mexico, especially in light of the forthcoming US elections.
“The long-term outlook remains positive for Mexico, but the coming months may see some disruption. In addition, stock opportunities at this juncture are more constrained, even if aggregate equity market valuations are reasonable,” says Robert Davy, Emerging Market Equities Fund Manager at Schroders.
Read the complete insight here.
Read more

Global Trade
Trump ignites global trade war / Reactions
The USA itself will be the victim of Trump’s trade policy.

Private Debt
The case for private debt in real asset financing
What makes the combination of private debt and real assets particularly compelling in today’s market?

Schroders
Looking ahead: 30-year return forecasts
Higher returns are expected across asset classes, driven by stronger productivity growth for equities and elevated long-term central bank rate projections for bonds.

Quant Investing
AI and quantitative investing
Artificial intelligence applications go way beyond stock selection.

Bellevue Asset Management
Demographics and AI drive MedTech stocks
MedTech investment case: What makes it attractive, which trends stand out?